144 related articles for article (PubMed ID: 31362859)
1. 'Potential issues of morbidity, toxicity and dependence': Problematizing the up-scheduling of over-the-counter codeine in Australia.
Weier M; Farrugia A
Int J Drug Policy; 2020 Jun; 80():102538. PubMed ID: 31362859
[TBL] [Abstract][Full Text] [Related]
2. The impact of codeine re-scheduling on misuse: a retrospective review of calls to Australia's largest poisons centre.
Cairns R; Brown JA; Buckley NA
Addiction; 2016 Oct; 111(10):1848-53. PubMed ID: 27177599
[TBL] [Abstract][Full Text] [Related]
3. Regulatory responses to over-the-counter codeine analgesic misuse in Australia, New Zealand and the United Kingdom.
Tobin CL; Dobbin M; McAvoy B
Aust N Z J Public Health; 2013 Oct; 37(5):483-8. PubMed ID: 24090333
[TBL] [Abstract][Full Text] [Related]
4. Misuse of non-prescription codeine containing products: Recommendations for detection and reduction of risk in community pharmacies.
Van Hout MC; Norman I
Int J Drug Policy; 2016 Jan; 27():17-22. PubMed ID: 26454626
[TBL] [Abstract][Full Text] [Related]
5. Caution with the forthcoming rescheduling of over-the-counter codeine-containing analgesics.
Schug SA; Dobbin MD; Pilgrim JL
Med J Aust; 2018 Jan; 208(1):51-52. PubMed ID: 29320673
[No Abstract] [Full Text] [Related]
6. Up-scheduling and codeine supply in Australia: analysing the intervention and outliers.
Yu Y; Wilson M; King CE; Hill R
Addiction; 2021 Dec; 116(12):3463-3472. PubMed ID: 33999465
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional analysis of over-the-counter codeine use among an Australian sample of people who regularly inject drugs.
Arora S; Roxburgh A; Bruno R; Nielsen S; Burns L
Drug Alcohol Rev; 2013 Nov; 32(6):574-81. PubMed ID: 23751176
[TBL] [Abstract][Full Text] [Related]
8. A wastewater-based evaluation of the effectiveness of codeine control measures in Australia.
Tscharke BJ; O'Brien JW; Ahmed F; Nguyen L; Ghetia M; Chan G; Thai P; Gerber C; Bade R; Mueller J; Thomas KV; White J; Hall W
Addiction; 2023 Mar; 118(3):480-488. PubMed ID: 36367203
[TBL] [Abstract][Full Text] [Related]
9. Examining the construction and representation of drugs as a policy problem in Australia's National Drug Strategy documents 1985-2010.
Lancaster K; Ritter A
Int J Drug Policy; 2014 Jan; 25(1):81-7. PubMed ID: 23931957
[TBL] [Abstract][Full Text] [Related]
10. Use of analgesics following rescheduling of codeine in Australia: An interrupted time series analysis in the veteran population.
Kalisch Ellett LM; Kemp-Casey A; Kassie GM; Pratt NL; Roughead EE
Int J Drug Policy; 2020 Jul; 81():102767. PubMed ID: 32416524
[TBL] [Abstract][Full Text] [Related]
11. Best Practices and Innovations for Managing Codeine Misuse and Dependence.
Norman IJ; Bergin M; Parry CD; Van Hout MC
J Pharm Pharm Sci; 2016; 19(3):367-381. PubMed ID: 27806253
[TBL] [Abstract][Full Text] [Related]
12. Changes in sales of analgesics to pharmacies after codeine was rescheduled as a prescription only medicine.
Schaffer AL; Cairns R; Brown JA; Gisev N; Buckley NA; Pearson SA
Med J Aust; 2020 Apr; 212(7):321-327. PubMed ID: 32200566
[TBL] [Abstract][Full Text] [Related]
13. A prospective cohort study evaluating the impact of upscheduling codeine in Australia among frequent users of codeine.
McCoy J; Nielsen S; Bruno R
Addiction; 2022 Mar; 117(3):677-686. PubMed ID: 34490926
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: implications for intervention and prevention.
Nielsen S; Cameron J; Lee N
J Opioid Manag; 2011; 7(5):363-70. PubMed ID: 22165035
[TBL] [Abstract][Full Text] [Related]
15. Over-the-Counter Codeine-from Therapeutic Use to Dependence, and the Grey Areas in Between.
Nielsen S; Van Hout MC
Curr Top Behav Neurosci; 2017; 34():59-75. PubMed ID: 26768736
[TBL] [Abstract][Full Text] [Related]
16. Reduced gastrointestinal-related hospitalisation costs following rescheduling of over-the-counter codeine-containing compound analgesics in Australia: results of a single hospital audit in South Australia.
Mathias R; Howes B; Cock V; Cock C
Intern Med J; 2023 Dec; 53(12):2240-2246. PubMed ID: 37029690
[TBL] [Abstract][Full Text] [Related]
17. Commentary on McCoy et al.: More pieces of the mosaic describing outcomes of the Australian up-scheduling of over-the-counter codeine to prescription only.
Dobbin M; Nielsen S; Schumann JL
Addiction; 2022 Mar; 117(3):687-689. PubMed ID: 34622497
[No Abstract] [Full Text] [Related]
18. Codeine use and harms in Australia: evaluating the effects of re-scheduling.
Cairns R; Schaffer AL; Brown JA; Pearson SA; Buckley NA
Addiction; 2020 Mar; 115(3):451-459. PubMed ID: 31577369
[TBL] [Abstract][Full Text] [Related]
19. The impact of proposed regulatory changes and rescheduling on low-dose codeine purchasing in Canada: a time-series analysis.
Boone CG; Antoniou T; Juurlink DN; von den Baumen TR; Kitchen SA; Richards GC; Tadrous M; Gomes T
CMAJ Open; 2021; 9(4):E1181-E1186. PubMed ID: 34906994
[TBL] [Abstract][Full Text] [Related]
20. Changes in Australian prescription opioid use following codeine rescheduling: A retrospective study using pharmaceutical benefits data.
Middleton M; Nielsen S
Int J Drug Policy; 2019 Dec; 74():170-173. PubMed ID: 31622949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
